Similarly, Tanaka et al. (2006[43]) suggested the Gelsolin controlled E- and N-cadherin conversion; they demonstrated that Gelsolin knock-down led to epithelial-mesenchymal transition in human mammary epithelial cells and might be involved in human mammary tumors development. Here, CDH2 is linked to breast cancer.